Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 12:02 PM
Ignite Modification Date:
2025-12-24 @ 12:02 PM
NCT ID:
NCT05844761
Eligibility Criteria:
Inclusion Criteria:
For prostate cancer patients:
* Patients histologically proven prostate adenocarcinoma
* Prostate specific antigen (PSA) obtained within three months prior to enrollment
* Localised prostate cancer at any stage eligible for radiotherapy: i.e. any T- or Gleason stage, but no pelvic lymph nodes can be included within the target to be treated
* Eastern Cooperative Oncology Group (ECOG) performance status 0-2
* Ability to understand and the willingness to sign a written informed consent document.
* Hypofractionated radiation therapy (HYPO) fractionated patients with a prescribed dose of 42.7Gy in 7 fractions.
* MRIOnly workflow meaning synthetic generated CT based on Magnetic resonance imaging (MRI)
* Patients over 40 years old
For lung cancer patients:
* Lung cancer or localised metastatic disease from other cancer diagnoses, accepted for stereotactic radiotherapy to 45Gy in 3 fractions
* Lesion distinguishable on Computer Tomography and where the majority of adjacent tissue is the lung.
* Ability to understand and the willingness to sign a written informed consent document.
* Is able to perform treatment simulation
Exclusion Criteria:
For prostate cancer patients:
* Patient must have three gold fiducial markers inserted in the prostate
* Patients with artificial Hip(s), lumbar spinal surgical rods or other large metallic pelvic implants
* Patients with overlapping implanted gold fiducials in X-ray imaging
* Unfeasible to track fiducials with kv imaging/existing online imaging systems
For lung cancer patients:
* Previous treatment with radiotherapy for lung cancer or lung metastasis
* Idiopathic lung fibrosis
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT05844761
Study Brief:
Protocol Section:
NCT05844761